OSILODROSTAT
Total Payments
$276,920
Transactions
511
Doctors
28
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $276,920 | 511 | 28 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $206,437 | 475 | 74.5% |
| Honoraria | $30,465 | 15 | 11.0% |
| Consulting Fee | $24,104 | 17 | 8.7% |
| Travel and Lodging | $15,914 | 4 | 5.7% |
Payments by Type
Research
$206,437
475 transactions
General
$70,483
36 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| LCI699-RECAG-PASS-0572 | RECORDATI_RARE_DISEASES_INC. | $155,900 | 15 |
| CLCI699C2203 | RECORDATI_RARE_DISEASES_INC. | $50,537 | 1 |
Top Doctors Receiving Payments for OSILODROSTAT
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Atlanta, GA | $98,301 | 217 |
| , MD | Endocrinology, Diabetes & Metabolism | Portland, OR | $26,977 | 9 |
| , M.D | Pediatric Endocrinology | Bethesda, MD | $25,268 | 11 |
| , MD | Internal Medicine | Boston, MA | $18,762 | 5 |
| , M.D | Internal Medicine | Rochester, MN | $13,753 | 83 |
| , MD | Internal Medicine | Ann Arbor, MI | $13,235 | 5 |
| , MD | Internal Medicine | Charlottesville, VA | $10,717 | 22 |
| , MBCHB, MD, FRCP(UK) | Endocrinology, Diabetes & Metabolism | Phoenix, AZ | $8,640 | 3 |
| , MD | Endocrinology, Diabetes & Metabolism | Milwaukee, WI | $8,156 | 13 |
| , MD | Endocrinology, Diabetes & Metabolism | Florence, KY | $7,511 | 10 |
| Nidhi Agrawal | Endocrinology, Diabetes & Metabolism | New York, NY | $7,419 | 12 |
| , MD | Endocrinology, Diabetes & Metabolism | Portland, OR | $4,605 | 24 |
| , MD | Endocrinology, Diabetes & Metabolism | Ann Arbor, MI | $4,200 | 3 |
| , MD | Endocrinology, Diabetes & Metabolism | New York, NY | $4,147 | 41 |
| , D.O | Endocrinology, Diabetes & Metabolism | Dallas, TX | $3,660 | 3 |
| , M.D | Endocrinology, Diabetes & Metabolism | Houston, TX | $3,500 | 2 |
| , MD | Endocrinology, Diabetes & Metabolism | Boston, MA | $3,444 | 15 |
| , M.D | Endocrinology, Diabetes & Metabolism | New York, NY | $3,250 | 2 |
| , MD | Internal Medicine | Indianapolis, IN | $1,764 | 5 |
| , M.D | Endocrinology, Diabetes & Metabolism | Los Angeles, CA | $1,750 | 3 |
| , M.D | Endocrinology, Diabetes & Metabolism | Summerville, SC | $1,750 | 2 |
| , M.D | Internal Medicine | Winston Salem, NC | $1,704 | 2 |
| , MD | Endocrinology, Diabetes & Metabolism | Philadelphia, PA | $1,622 | 3 |
| , M.D | Endocrinology, Diabetes & Metabolism | Los Angeles, CA | $650.00 | 1 |
| , MD | Endocrinology, Diabetes & Metabolism | Saint Louis, MO | $624.04 | 11 |
Ad
Manufacturing Companies
- RECORDATI_RARE_DISEASES_INC. $276,920
Product Information
- Type Drug
- Total Payments $276,920
- Total Doctors 28
- Transactions 511
About OSILODROSTAT
OSILODROSTAT is a drug associated with $276,920 in payments to 28 healthcare providers, recorded across 511 transactions in the CMS Open Payments database. The primary manufacturer is RECORDATI_RARE_DISEASES_INC..
Payment data is available from 2024 to 2024. In 2024, $276,920 was paid across 511 transactions to 28 doctors.
The most common payment nature for OSILODROSTAT is "Unspecified" ($206,437, 74.5% of total).
OSILODROSTAT is associated with 2 research studies, including "LCI699-RECAG-PASS-0572" ($155,900).